Results 121 to 130 of about 24,458,404 (212)

Atypical diabetes mellitus in children - when to suspect drug-induced diabetes. A case-based review of the literature. [PDF]

Pediatr Endocrinol Diabetes Metab, 2022
A Okruszko M, Szabłowski M, Pochodowicz K, Taranta-Janusz K, Bossowski A, Głowińska-Olszewska B.   +5 more
europepmc   +1 more source

Cross-sectional evaluation of people with type 1 diabetes participating in the GoPump Structured Diabetes Education Program during "Insulin Pump Weeks". [PDF]

Pediatr Endocrinol Diabetes Metab
Najmanowicz M, Gajda W, Nowatkowska A, Kamiński M, Cieluch A, Sroczyńska A, Kreczmer A, Michalak M, Adamska A, Frąckowiak U, Michalski M, Araszkiewicz A, Zozulińska-Ziółkiewicz D, Gawrecki A.   +13 more
europepmc   +1 more source

Early functional and metabolic disorders in children with type I diabetes mellitus and diabetic nephropathy. [PDF]

Pediatr Endocrinol Diabetes Metab, 2021
Burlaka I, Maidannyk V.
europepmc   +1 more source

Cukrzyca 2 typu — terapia wspomagająca. Wybrane suplementy oraz rola probiotyków i aktywności fizycznej

, 2013
Marta Matuszak, Joanna Suliburska
openalex   +1 more source

Less common forms of diabetes in young population. [PDF]

Pediatr Endocrinol Diabetes Metab
Tekielak A, Otto-Buczkowska E, Rusak E.
europepmc   +1 more source

Continuous glucose monitoring systems in well-controlled children with type 1 diabetes mellitus. [PDF]

Pediatr Endocrinol Diabetes Metab, 2021
M Kowalczyk E, Adamczyk M, Pietrzyk J, Jastrzębska B, Szypowska A.   +4 more
europepmc   +1 more source

Environmental triggers of pediatric type 1 diabetes: A protocol for a systematic review and meta-analysis on the impact of COVID-19 infection and vaccination. [PDF]

Pediatr Endocrinol Diabetes Metab
Kamińska-Jackowiak O, Kolasa M, Chobot A, Dos Santos T.   +3 more
europepmc   +1 more source

Availability of psychological care in pediatric diabetes centers - a real need? [PDF]

Pediatr Endocrinol Diabetes Metab, 2023
Kamińska-Jackowiak O, Malatyńska A, Chobot A, Gajewska KA.   +3 more
europepmc   +1 more source

FGF-21 – czy może być obiecującym lekiem w terapii cukrzycy typu 2? [PDF]

Diabetes type 2 has become an increasing global health problem in recent years and cardiovascular complications are the leading cause of death in this group of patients.
Lenart-Lipińska, Monika, Matuszek, Beata, Solski, Janusz   +2 more
core  

Complications of obesity in children and youths with type 1 diabetes mellitus. [PDF]

Pediatr Endocrinol Diabetes Metab
Kącka-Stańczak A, Charemska-Ronchini A, Odyjewska E, Jarocka-Cyrta E, Głowińska-Olszewska B.   +4 more
europepmc   +1 more source